Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$3.06 - $51.61 $30,600 - $516,100
-10,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$29.34 - $35.0 $70,416 - $84,000
2,400 Added 31.58%
10,000 $343,000
Q2 2018

Aug 14, 2018

BUY
$27.33 - $41.46 $16,398 - $24,876
600 Added 8.57%
7,600 $245,000
Q1 2018

May 15, 2018

BUY
$20.21 - $32.0 $141,470 - $224,000
7,000 New
7,000 $202,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $99M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.